________________________________________________________
____Explicit____
191..196
1,1,1,0,1,1,1
#### Text ####
still
##############
#### Features ####
Ot, Comm, Null, Null
135..165
1,0;1,1,0;1,2
#### Text ####
The biotechnology concern said
##############
still, Comparison.Contrast
____Arg1____
26..131
0,1,1
#### Text ####
the government of Spain approved the marketing of its Proleukin interleukin-2 drug to treat kidney cancer
##############
#### Features ####
Ot, Comm, Null, Null
9..25
0,0;0,1,0;0,2
#### Text ####
Cetus Corp. said
##############
____Arg2____
166..190;197..230
1,1,1,0,0;1,1,1,0,1,0;1,1,1,0,1,1,0;1,1,1,0,1,1,2
#### Text ####
Spanish authorities must clear the price for the treatment
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Explicit____
232..235
1,1,1,2
#### Text ####
but
##############
#### Features ####
Ot, Comm, Null, Null
135..165
1,0;1,1,0;1,2
#### Text ####
The biotechnology concern said
##############
but, Expansion.Conjunction
____Arg1____
166..230
1,1,1,0
#### Text ####
Spanish authorities must still clear the price for the treatment
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
236..288
1,1,1,3
#### Text ####
that it expects to receive such approval by year end
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Implicit____
290
2
#### Features ####
Wr, Comm, Null, Null
also, Expansion.Conjunction
____Arg1____
135..288
1
#### Text ####
The biotechnology concern said Spanish authorities must still clear the price for the treatment, but that it expects to receive such approval by year end
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
290..361
2
#### Text ####
Four other countries in Europe have approved Proleukin in recent months
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
________________________________________________________
____Implicit____
363
3
#### Features ####
Wr, Comm, Null, Null
also, Expansion.Conjunction
____Arg1____
290..361
2
#### Text ####
Four other countries in Europe have approved Proleukin in recent months
##############
#### Features ####
Inh, Null, Null, Null
____Arg2____
363..449
3
#### Text ####
Cetus is currently trying to obtain federal regulatory clearance for U.S. distribution
##############
#### Features ####
Inh, Null, Null, Null
________________________________________________________
